| Health / Medical Topics |
MDM2 Inhibitor DS-3032b
An orally available MDM2 (murine double minute 2) antagonist with potential antineoplastic activity. Upon oral administration, MDM2 inhibitor DS-3032b binds to, and prevents the binding of MDM2 protein to the transcriptional activation domain of the tumor suppressor protein p53. By preventing this MDM2-p53 interaction, the proteosome-mediated enzymatic degradation of p53 is inhibited and the transcriptional activity of p53 is restored. This results in the restoration of p53 signaling and leads to the p53-mediated induction of tumor cell apoptosis. MDM2, a zinc finger protein and a negative regulator of the p53 pathway, is overexpressed in cancer cells; it has been implicated in cancer cell proliferation and survival. (NCI Thesaurus)
YOU MAY ALSO LIKE
This gene plays a role in several cellular processes related to cellular viability; including the cell cycle and apoptosis.
An orally available, small molecule, antagonist of MDM2 (mouse double minute 2; Mdm2 p53 binding protein homolog), with potential antineoplastic activity. RO5503781…
An MDM2 (human homolog of double minutes-2; HDM2) antagonist with potential antineoplastic activity. RO5045337 binds to MDM2, thereby preventing the binding of…
A drug that belongs to a family of drugs called ribonucleotide reductase inhibitors.
Human MDK wild-type allele is located in the vicinity of 11p11.2 and is approximately 2 kb in length. This allele, which encodes…
This gene is involved in nervous tissue development. It plays a role in neuronal differentiation, growth, regeneration and survival.
